Methods of promoting blood flow within the vasculature of a mammal
    51.
    发明授权
    Methods of promoting blood flow within the vasculature of a mammal 失效
    促进哺乳动物脉管系统内血流的方法

    公开(公告)号:US06448221B1

    公开(公告)日:2002-09-10

    申请号:US09506855

    申请日:2000-02-17

    IPC分类号: C07K100

    CPC分类号: A61K38/1709

    摘要: The present invention relates to polynucleotide and polypeptide molecules for use as inhibitors in hemostasis and immune function. Such inhibitors are members of the family of proteins bearing a collagen-like domain and a globular domain. The inhibitors are useful for promoting blood flow in the vasculature by reducing thrombogenic and complement activity. The inhibitors are also useful for pacifying collagenous surfaces and modulating wound healing.

    摘要翻译: 本发明涉及用作止血和免疫功能抑制剂的多核苷酸和多肽分子。 这种抑制剂是具有胶原样结构域和球状结构域的蛋白家族的成员。 抑制剂可用于通过降低血栓形成和补体活性来促进脉管系统中的血液流动。 抑制剂也可用于平缓胶原表面和调节伤口愈合。

    Nucleic acid which encodes the tumor marker ZSIG62
    52.
    发明授权
    Nucleic acid which encodes the tumor marker ZSIG62 失效
    编码肿瘤标志物ZSIG62的核酸

    公开(公告)号:US06403783B1

    公开(公告)日:2002-06-11

    申请号:US09493565

    申请日:2000-01-18

    IPC分类号: C07H2104

    CPC分类号: C07K14/4703 C07K14/4748

    摘要: Studies indicate that mutations in tumor suppressor genes occur early in the process of carcinogenesis, and that these mutations are correlated with a subsequent development of cancer. The detection of such alterations would provide useful molecular markers for diagnosis, surveillance, early tumor identification and intervention, and prognosis. A novel human gene, designated as “Zsig62,” resides within a region of chromosome 16q that is associated with prostate and breast cancer, and that appears to contain tumor suppressor genes. Like a tumor suppressor gene, the Zsig62 gene is expressed in particular normal tissues, but not in tumors derived from those tissues.

    摘要翻译: 研究表明,肿瘤抑制基因突变在致癌过程的早期发生,这些突变与随后的癌症发展相关。 这种改变的检测将为诊断,监测,早期肿瘤鉴定和干预以及预后提供有用的分子标记。 称为“Zsig62”的新型人类基因位于与前列腺和乳腺癌相关的染色体16q的区域中,并且似乎含有肿瘤抑制基因。 像肿瘤抑制基因一样,Zsig62基因在特定的正常组织中表达,但不是来源于那些组织的肿瘤。

    Islet cell antigen 1851
    53.
    发明授权
    Islet cell antigen 1851 失效
    胰岛细胞抗原1851

    公开(公告)号:US06300093B1

    公开(公告)日:2001-10-09

    申请号:US08811481

    申请日:1997-03-05

    IPC分类号: C12P2106

    摘要: A mammalian islet cell antigen polypeptide involved in the development of insulin-dependent diabetes mellitus (IDDM) is disclosed. This islet cell antigen polypeptide, 1851, was found to contain regions of homology to the protein tyrosine phosphatase family. Methods for diagnosis and treatment, including use in immunoprecipitation assays and the induction of immune tolerance using the recombinant mammalian polypeptides and antibodies specific to mammalian islet cell antigen 1851 polypeptides are presented.

    摘要翻译: 公开了涉及胰岛素依赖性糖尿病(IDDM)发展的哺乳动物胰岛细胞抗原多肽。 该胰岛细胞抗原多肽1851被发现含有与蛋白酪氨酸磷酸酶家族同源的区域。 提出了用于诊断和治疗的方法,包括在免疫沉淀测定中的应用和使用重组哺乳动物多肽和对哺乳动物胰岛细胞抗原1851多肽特异的抗体诱导免疫耐受。

    Cytokine Protein Family
    56.
    发明授权
    Cytokine Protein Family 有权
    细胞因子蛋白家族

    公开(公告)号:US08124065B2

    公开(公告)日:2012-02-28

    申请号:US13028101

    申请日:2011-02-15

    IPC分类号: A61K38/00 A61K45/00 C07K14/00

    CPC分类号: C07K14/56 C12Q2600/158

    摘要: The present invention relates to polynucleotide and polypeptide molecules for zcyto20, zcyto21, zcyto22, zycto24, and zcyto25 proteins which are most closely related to interferon-α at the amino acid sequence level. The receptor for this protein family is a class II cytokine receptor. The present invention includes methods of reducing viral infections and increasing monocyte counts. The present invention also includes antibodies to the zcyto20 polypeptides, and methods of producing the polynucleotides and polypeptides.

    摘要翻译: 本发明涉及与氨基酸序列水平上与干扰素-α最密切相关的zcyto20,zcyto21,zcyto22,zycto24和zcyto25蛋白的多核苷酸和多肽分子。 该蛋白家族的受体是II类细胞因子受体。 本发明包括减少病毒感染和增加单核细胞计数的方法。 本发明还包括针对zcyto20多肽的抗体,以及产生多核苷酸和多肽的方法。

    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
    57.
    发明申请
    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS 有权
    使用截短的CYSTEINE IL28和IL29突变体治疗癌症和自身免疫性疾病

    公开(公告)号:US20110177024A1

    公开(公告)日:2011-07-21

    申请号:US13042210

    申请日:2011-03-07

    申请人: Paul O. Sheppard

    发明人: Paul O. Sheppard

    IPC分类号: A61K38/20 A61P37/06

    摘要: Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and IL-29 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer and/or autoimmune therapeutics.

    摘要翻译: 使用IL-28和IL-29分子治疗患有癌症和自身免疫疾病的患者的方法。 IL-28和IL-29分子包括与人IL-28或IL-29多肽序列具有同源性的多肽,以及与具有IL-28和IL-29功能活性的多肽融合的蛋白质。 分子可以用作单一疗法或与其它已知的癌症和/或自身免疫治疗剂组合使用。

    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
    58.
    发明申请
    USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS 审中-公开
    使用截短的CYSTEINE IL28和IL29突变体治疗癌症和自身免疫性疾病

    公开(公告)号:US20100298230A1

    公开(公告)日:2010-11-25

    申请号:US12611067

    申请日:2009-11-02

    申请人: Paul O. Sheppard

    发明人: Paul O. Sheppard

    摘要: Methods for treating patients with cancer and autoimmune disorders using IL-28 and IL-29 molecules. The IL-28 and IL-29 molecules include polypeptides that have homology to the human IL-28 or IL-29 polypeptide sequence and proteins fused to a polypeptide with IL-28 and IL-29 functional activity. The molecules can be used as a monotherapy or in combination with other known cancer and/or autoimmune therapeutics.

    摘要翻译: 使用IL-28和IL-29分子治疗患有癌症和自身免疫疾病的患者的方法。 IL-28和IL-29分子包括与人IL-28或IL-29多肽序列具有同源性的多肽,以及与具有IL-28和IL-29功能活性的多肽融合的蛋白质。 分子可以用作单一疗法或与其它已知的癌症和/或自身免疫治疗剂组合使用。

    ZSIG33-like polynucleotides
    60.
    发明授权
    ZSIG33-like polynucleotides 有权
    ZSIG33样多核苷酸

    公开(公告)号:US07655447B2

    公开(公告)日:2010-02-02

    申请号:US12239535

    申请日:2008-09-26

    摘要: The present invention relates to polynucleotide related to the zsig33 peptide, including agonists, antagonists, and antibodies. Methods of modulating gastric contractility, nutrient uptake, growth hormones, the secretion of digestive enzymes and hormones, and/or secretion of enzymes and/or hormones in the pancreas are also included.

    摘要翻译: 本发明涉及与zsig33肽相关的多核苷酸,包括激动剂,拮抗剂和抗体。 还包括调节胃收缩力,营养摄取,生长激素,消化酶和激素分泌和/或胰腺中酶和/或激素分泌的方法。